StockData
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31

NEUTRA CORP.

Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

NEUTRA CORP. revenue by segment

No segment breakdown reported

Neutra does not break out revenue by segment, region or product in the tagged data of its filings for this period type.